Analogs of pulmicort for inhalation

Pulmicort is a potent drug with an active component from the pharmacological group of glucocorticosteroids. Because of this, the medication has a number of contraindications, so it is used only as prescribed by a doctor.

But today, a number of drugs similar to Pulmicort have been developed that are not inferior to it in effectiveness, but are cheaper and safer.

Let's look at popular products that can replace Pulmicort:

Benacort

Synthetic GCS with the active component - budesonide. Has anti-inflammatory, antiallergic and immunosuppressive properties. Promotes increased sensitivity of the bronchi to bronchodilators, reduces swelling of the mucous membrane and the production of mucus, sputum.

• Indications for use: chronic obstructive pulmonary disease, bronchial asthma and other conditions requiring treatment with inhaled GCS.
• Method of application: the drug is used for inhalation using a nebulizer or a metered-dose inhaler Cyclohaler. The dosage and duration of therapy is determined by the attending physician. Therapy begins with minimal doses, gradually increasing the concentration of the drug.
• Side effects: cough, dry mouth, headaches, dysphonia, hoarseness, oral stomatitis, irritation of the oropharyngeal mucosa.
• Contraindications: intolerance to the components of the drug, patients under 16 years of age. It is prescribed with special caution in case of pulmonary tuberculosis, infectious diseases of the respiratory system, pathologies of viral, fungal or bacterial etiology. Use during pregnancy is possible in cases where the expected benefit to the mother is higher than the potential risks to the fetus.
• Overdose: a single excess of prescribed doses does not cause clinical symptoms. With prolonged overdose, disorders in the functioning of the adrenal glands and hypercorticism develop.

Release form: powder of 200 mcg budesonide in 100 and 200 dose inhalers; solution for inhalation through a nebulizer 0.25 and 0.5 mg in 1 and 2 ml vials.

Budenit Steri Neb

Inhalation suspension with the active component budesonide. Has anti-inflammatory, antiexudative and antiallergic properties.

• Indications for use: bronchial asthma, chronic obstructive pulmonary disease. The drug is not intended to relieve acute attacks of bronchial asthma. Short-acting bronchodilators should be used for these purposes.
• Method of administration: inhalation using a nebulizer or a metered-dose device. Adults and children over 12 years of age are prescribed 1-2 mg 2 times a day, for patients from 12 months to 12 years of age - 0.25-0.5 mg 2 times a day. The duration of therapy is determined by the attending physician.
• Contraindications: hypersensitivity to the components of the drug, patients under 12 months of age. Use during pregnancy and lactation is possible only for strict medical indications.
• Overdose: if the dosage prescribed by the doctor is exceeded for a long time, a systemic GCS effect and suppression of the adrenal function develop. For treatment, a gradual reduction in dosage until complete withdrawal of the drug is indicated.

Release form: suspension for inhalation in ampoules of 2 ml, in packages of 20 and 60 ampoules.

Budesonide

Glucocorticoid for local and inhalation use. Budesonide has anti-inflammatory and antiallergic effects. After inhalation, a pronounced clinical effect develops within 5-7 days of course therapy.

• Indications for use: asthmatic bronchitis, bronchial asthma, inflammation of the mucous membrane of the nasal cavity, seasonal and allergic rhinitis. Used for the prevention of nasal polyps after their surgical removal.
• Method of administration: inhalation, for adults 400-1600 mcg per day in 2-4 doses, then 200-400 mcg 2 times a day. The dosage for children and the duration of treatment are determined by the attending physician.
• Side effects: oral and throat candidiasis, hoarseness, throat irritation. To prevent stomatitis, rinse your mouth with warm water after each inhalation.
• Contraindications: individual intolerance to the components of the drug, viral diseases of the respiratory system and skin, tuberculosis. Use during pregnancy and lactation is possible for strict medical indications.

Release form: metered-dose aerosol for 200 doses, suspension for inhalation through a nebulizer.

[ 1 ], [ 2 ], [ 3 ]

Tafen Novolizer

Budesonide in powder form for inhalation use. Tafen has an anti-inflammatory effect on the bronchial mucosa, reduces their hyperreactivity and restores breathing.

• Indications for use: bronchial asthma, chronic obstructive pulmonary disease and other pathologies of the upper respiratory tract.
• Method of administration: inhalation 200-1600 mcg/day, average daily dose 400 mcg for adults. For children, 200-400 mcg per day is prescribed. The course of treatment is long and is monitored by the attending physician.
• Side effects: sneezing and coughing, throat irritation, loss of smell, dizziness, dry mouth, allergic rashes, increased anxiety, angioedema, stomatitis.
• Contraindications: hypersensitivity to the components of the drug, patients under 6 years of age, fungal infections of the respiratory system, viral and bacterial ENT infections, pulmonary tuberculosis. It is prescribed with caution during pregnancy and lactation, in case of renal failure, in the postoperative period after surgical treatment of the respiratory tract.
• Overdose: Systemic overdose may cause signs of hypercorticism. Treatment involves reducing the dose and discontinuing the drug.

Release form: powder for inhalation in dosed bottles of 200 doses.

Budekort

Metered aerosol for inhalation with the active substance budesonide. Belongs to the pharmacological group of glucocorticoids. Used for the treatment and prevention of bronchopulmonary diseases.

• Indications for use: bronchial asthma, COPD.
• Method of application: the medicine is used for inhalation using a spacer or nebulizer. It is recommended to carry out the procedures twice a day - in the morning before meals and in the evening before bedtime. The dosage for adults is 200 mcg 2 times a day, for children over 6 years old 50-400 mcg twice a day. After achieving the desired therapeutic effect, the dose is reduced to the minimum effective.
• Contraindications: intolerance to the components of the drug, active form of pulmonary tuberculosis, first trimester of pregnancy, respiratory tract infections of fungal or viral etiology, asthmatic status, frequent and severe bronchospasms, patients under 6 years of age.
• Side effects: hoarseness, dry throat and cough, mycosis of the pharynx and larynx. To prevent these symptoms, rinse your mouth with warm water after each inhalation.
• Overdose: With prolonged use of high doses, systemic effects develop: growth retardation in children, decreased bone mineral density, cataracts, glaucoma, and adrenal suppression.

Release form: aluminum container with a dosing valve, sprayer and protective cap for 100 and 200 injection doses.

Pulmicort for inhalation is a prescription drug, so it should be taken only as prescribed by a doctor, strictly following the dosage and duration of therapy.